Entering text into the input field will update the search result below

Adamis Pharmaceuticals misses on revenue

Aug. 10, 2018 9:04 AM ETDMK Pharmaceuticals Corporation (DMKPQ) StockBy: Niloofer Shaikh, SA News Editor
  • Adamis Pharmaceuticals (NASDAQ:ADMP): Q2 Net loss of $9.7M.
  • Revenue of $3.9M (+2.4% Y/Y) misses by $0.08M.
  • Press Release

Recommended For You

More Trending News

About DMKPQ Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
DMKPQ--
DMK Pharmaceuticals Corporation